Sustained cellular immune dysregulation in individuals recovering from COVID-19

COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path. Many infected patients remain asymptomatic or have mild symptoms. Others, especially those with comorbidities, can develop severe clinical disease with atypical pneumonia and multiple system organ failure.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news